Key Highlights:
- AstraZeneca India has signed an MoU with the Government of Telangana to introduce AI-enabled lung cancer screening across public healthcare facilities, aiming to improve early detection and outcomes
- The program will integrate Qure.ai’s AI-powered chest X-ray solution into routine workflows to flag high-risk pulmonary nodules and triage patients, supporting earlier diagnosis and follow-up across urban and rural settings
- The initiative is expected to roll out across ~20 public health facilities with training, infrastructure support, and clinician upskilling, addressing rising cancer burden and late-stage diagnosis challenges in the state
Implications:
AstraZeneca India is partnering with Telangana to embed Qure.ai’s chest X‑ray AI into routine workflows at about 20 public facilities, turning basic radiography into a lung-cancer triage tool that flags high‑risk nodules and routes patients for earlier CT, confirmation, and follow‑up.
By combining technology deployment with training, infrastructure support, and a focus on both urban and rural hospitals, the programme aims to chip away at India’s late‑stage lung cancer problem—where 80–85% of cases are diagnosed advanced—while building a scalable public-sector model that could be replicated beyond Telangana.
Source: AstraZeneca India | Image: AstraZeneca
